Background: antipsychotics are widely used in assisted living (AL facilities). Even more, the prescription of these drugs is gradually increasing since the availability of second-generation atypical antipsychotics. More knowledge is needed on prescription reasons to understand this increasing prevalence.
Methods: cross-sectional analysis of 4,367 residents. Data were obtained from medical records assessed by geriatricians from the AL facility. A multiple logistic regression model (backward stepwise) was used to assess the independent associated factors with antipsychotic use. Results: antipsychotic prescription was found in 1,203 (27.5%) of 4,367 residents. The independent associated factors with the use of antipsychotics were the presence of a psychiatric disorder [odds ratio, OR = 5. Conclusions: the study found that more than a quarter of the residents received antipsychotics. This study also highlighted the independent associated factors with antipsychotic prescription showing 'off-label' prescriptions in conditions such as dementia and certain NPS. The study findings suggest that improvements in the management of dementia and NPS in AL facilities are needed. Non-pharmacological alternatives should be enhanced and further developed viewing the high prevalence of antipsychotic prescription.
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Background
Antipsychotics are widely used in assisted living (AL) facilities with a prevalence of 20-30% among residents [1, 2] . The prescription has gradually increased since the availability of second-generation atypical antipsychotics. An American study conducted in 2005 detected at the time, the highest level, over a decade, of antipsychotic use in nursing homes (NH) with many antipsychotic prescriptions 'off-labelled', and with doses and indications not based on sounded clinical evidence [2] . Even if European and American regulators highlighted the risk and the 'off-label' use of antipsychotics with warnings of excess mortality and vascular strokes associated with the use of antipsychotics for neuropsychiatric symptoms (NPS), and a recent trial showed that side effects of antipsychotics offset advantages, scarce attention has been paid to antipsychotic prescription in older people [3] [4] [5] [6] . Moreover, even fewer studies have examined antipsychotic use in NH knowing that their use was 9 times higher among NH residents than among community-dwelling older people [7] . But the published evidence on the effectiveness of antipsychotics in older adults with dementia provides little support for their use and a recent systematic review found only five trials that assessed antipsychotic therapy in older adults with dementia. These trials included only small populations, showed relatively little benefit, were of short duration, and none of them compared different antipsychotics [8] .
Finally, a major issue behind this evidence, other than 'off-label' prescriptions, could be the absence of discontinuation of antipsychotics at the time of NH admission, due to the uncertain, absent or lost clinical indication in medical records. The use of antipsychotics could therefore be continued even when a labelled clinical indication is lacking [9] .
In the light of the present controversies, the aim of the present study was to examine the prevalence and the independent associated factors with the use of antipsychotics among residents from AL facilities in France.
Methods

Study design
This study used data from the functional network established in collaboration between the Geriatric Department of Toulouse University Hospital and geriatricians working in 236 AL facilities around France. The aim of this network was to perform clinical research in the field of usual care in institutionalised older adults and to improve current knowledge on the quality of care of these residents. [10] .
Between January and March 2008, the geriatrician from the AL facility completed a questionnaire based on medical records of residents. The residents were selected as follows: in AL facilities with less than 60 beds, all residents born in January, March, July and October, whatever the year of birth, were included, while in AL facilities with more than 60 beds, only residents born in March, July and October were included. No exclusion criteria were established other than resident refusal to participate.
Local ethics committee at the Toulouse University Hospital approved the study protocol.
Covariates
The medical questionnaire contained socio-demographic characteristics (age, gender, housing status before institutionalisation and length of stay in the current AL facility), and the medical history of past and current affections with completion of the Charlson index for comorbidities [11] , the presence (yes/no) of psychiatric disorders (including past episodes of depression), NPS (threatening behaviours or physical violence, aimless wandering, verbal outbursts, wandering away from institution) and presence of current depressive episodes. The diagnosis of dementia and specific treatment (cholinesterase inhibitors or memantine) was collected from the records. The presence of antipsychotics and antidepressants were specifically noted. For all treatments, only current and daily administrated drugs were registered. Pro Re Nata (PRN) prescriptions were not accounted for. Function was assessed using the Katz's activities of daily living (ADL) scale (transfers, walking aid, dressing, toileting, eating and continence) [12] .
Statistical analyses
Data were analysed with STATA 11 software (Stata Corp., College Station, TX).
When a variable presented a normal distribution, the mean and standard deviation were given; when not normal, the median and interquartile range (IR) were supplied. For the purpose of analyses, variables were categorised based on meaningful clinical cut-points, when available, or on distribution characteristics. Comparisons of the discrete outcome variables were performed using chi-square (χ ²) statistics or Fisher's exact test when necessary. An exploratory and saturated backward stepwise logistic regression model controlled for all potential confounders (with P-value under 0.20 in univariate analysis): age, gender, years of institutionalisation, housing status before institutionalisation, depression, NPS, ADL score and Charlson index) was constructed to assess the independent associated factors with a prescription of antipsychotics. The model was fitted using the maximum likelihood method and null hypothesis of models was verified with a likelihood-ratio test. [13] A sub-analysis of residents with <3 months of institutionalisation was performed with a backward stepwise logistic regression model in order to identify the possible NH prescription modifications over time. Due to the small number of residents in some of the classes, this model was forced with all variables of the full model (independently of P-values of sub-analysis).
Results
Of the initial 4,896 NH residents, 4,367 (89.2 %) participants had full data on antipsychotic use and were included in the current study. The median age of the NH residents was 87 years (IR: 81-92), mainly women (73.5%), 44.6% had a diagnosis of dementia and a third were autonomous (score ADL of 4.5 or more over 6) with a median length of stay of 2.75 years (IR: 1.16-5.42). Table 1 shows main characteristics by antipsychotic prescription. Among the 4,367 NH residents, antipsychotic use was found in 1,203 (27.5%). Briefly, younger residents (<80 years) took more often antipsychotics (45.3 %); residents suffering from dementia had more often antipsychotic prescription (34.2% versus 22.6%), the presence of NPS were associated with increased antipsychotic use, and a prescription of antipsychotics was made in 33.5% of residents suffering from depression. 
Discussion
The current study provides evidence that antipsychotics are widely prescribed in AL facilities. The independent associated factors were the presence of a psychiatric disorder, younger age, admission from acute care or from another institution, diagnosis of dementia whether treated or not, the presence of NPS and the presence of cardiovascular and cerebrovascular diseases. Psychiatric disorders, admission from acute care, falls, the presence of dementia whether treated or not, the presence of verbal outbursts and the presence of cerebrovascular disease were the independent associated factors for residents with <3 months of institutionalisation.
The prevalence of antipsychotic prescription (27.5%) and dementia (44.6%) was consistent with previous NH surveys [1, 2, [14] [15] [16] . The association of antipsychotic prescription with younger age and the non-association with gender was also comparable with previous studies [15, 17] , the same as a lower prescription in the presence of cardiovascular and cerebrovascular diseases [18, 19] suggesting consistency of the present analysis. The gradual and current increase of antipsychotic prescription in older people is presumed to be related to the availability of second-generation antipsychotics (with better side-effect profile), an increased frequency in 'off-label' prescription, and an increased access. As a result, community-dwelling older adults were 20 times more likely to receive antipsychotics between 2002 and 2004 than before 1998 [20] .
The main finding, other than the widespread use, was the presence of 'off-label' prescriptions. According to International guidelines, long-term use of antipsychotics is considered inappropriate, except for disorders with psychotic symptoms and agitation with delusion in demented residents [21, 22] . The current study revealed an association between dementia (whether treated or not), NPS (such as verbal outbursts and aimless wandering) and antipsychotic prescription. A prevalence of 70-87% 'off-label' indications for antipsychotics has been reported in previous studies, and NH residents diagnosed with dementia, anxiety or depression were more likely to receive antipsychotics than others [18, [21] [22] [23] [24] . This 'off-label' prescription is of special interest as recent regulator warnings have been published about an increased risk of death, stroke and transient ischaemic attack among elderly patients with dementia being treated with risperdone and olanzapine [3] . This risk is particularly high during the first 30 days of follow-up after treatment prescription. Indeed community-dwelling older adults suffering from dementia were 3 times more likely to die during a 30-day period when newly dispensed atypical antipsychotics [25] It is interesting to note that 'off-label' prescriptions have diminished in the presence of cardiovascular and cerebrovascular diseases following regulator warnings but this seems not to be the case for dementia and NPS. A main reason behind this issue could be that NPS are extremely difficult to manage, especially threatening behaviours, agitation, verbal outbursts or physical violence. Most guidelines suggest non-pharmacological treatments as the first-line therapy and there is emerging evidence that a variety of psychological and training interventions, including social interaction and person-centred care training, are effective [26] . Some atypical antipsychotic drugs confer benefit in the treatment of aggression in people with AD over a period of up to 12 weeks [26] [27] [28] . However, these benefits have to be considered in the context of significant side effects. Therefore, it is important to limit antipsychotic use to short-term periods. The evidence is even more limited for other pharmacological approaches [26] . As a result, nonpharmacological therapies offer a viable and effective treatment alternative for NPS, but it needs to be proved that staff training in the management of NPS with nonpharmacological approaches might be an effective way to diminish antipsychotic use in NH.
Finally, residents coming from acute care received more antipsychotics. The higher prescription of antipsychotics at discharge from acute care is probably due to the presence of NPS, mainly agitation due to delirium, during hospitalisation. Nevertheless antipsychotic prescription should have been re-evaluated at discharge. The present results with 'off-label' prescription and continuation at discharge suggest that the management of antipsychotics in hospital and at discharge needs improvement.
These findings were also found in the sub-analyses of 223 residents with <3 months of institutionalisation showing some huge disparities compared with the overall analyses.
Age was no longer associated with antipsychotic prescription, but in the line of previous findings, the odds for antipsychotics were increased 8 times when admitted from acute care. Falls were also independently associated with antipsychotic prescription when recently admitted but not in the global analyses. Probably best practice is performed in NH regarding antipsychotic discontinuation in the presence of falls. Regarding NPS, threatening behaviours and aimless wandering were not associated with antipsychotic use when recently admitted, so that the prescription could be presumed to be NH related. Finally the odds of antipsychotics in the presence of psychiatric disorders are the same in both populations evidencing a consistency of the performed analyses. The study was subject to limitations. First, due to the cross-sectional design, no conclusions can be made about causal relationship and due to the single-survey nature the NPS that fluctuate over time or the discontinuation of antipsychotics could not be assessed accurately. As a consequence, the exact nature of prescription reasons is not accurately known. Second, only characteristics of residents could be evaluated. Due to the study design (many AL facilities with few residents per centre), analyses at an institutional level could not be performed. Prescription rates across different AL facilities is influenced by size of the structure, the presence of specific architectural settings (like specific AD units), 'off-label' prescriptions of certain health carers compared with others, or the presence of structured non-pharmacological approaches of certain AL facilities.
[29] Future research is needed to determine why such a prescribing culture exists and whether it could result in adverse health consequences. Another limitation in the interpretation of the results was the non-availability of data on dementia severity and antipsychotic prescription across progressive stages of dementia could not be further explored. Finally, another limitation is PRN prescription. Only current treatments were recorded assuming that PRN administration was occasional. However this assumption could lead to an underestimation of antipsychotic prescription and increase even more the rates of drug use. Specific longitudinal studies will be needed to address the impact of PRN prescription in AL facilities.
Conclusions
The study found that more than a quarter of residents received antipsychotics. This study also highlighted the independent associated factors with antipsychotic prescription showing 'off-label' prescriptions in conditions such as dementia and certain NPS evidencing a gap between regulatory recommendations and clinical practice. ADL (score over 6).
These study findings suggest that quality of care in AL facilities needs to be improved when treating dementia and NPS, and non-pharmacological approaches could be alternatives to be further developed. It is encouraging however to notice that in the cases of cerebrovascular and cardiovascular diseases the residents were less likely to have an antipsychotic prescription in the line of recommendations of European and US health policies.
Key points
• Almost a third of the residents from AL facilities received antipsychotics.
• 'Off-label' prescriptions of antipsychotics have been identified, mainly in the case of dementia-affected residents with neuropsychiatric symptoms.
• Non-pharmacological approaches in AL facilities need further development and could be a feasible alternative for antipsychotic prescription.
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